Response to: Practical methods for incorporating summary time-to-event data into meta-analysis

doi:10.1186/1745-6215-14-391

Comment

. 2013 Nov 19;14(1):391.

doi: 10.1186/1745-6215-14-391.

Response to: Practical methods for incorporating summary time-to-event data into meta-analysis

Yu Wang, Tingting Zeng¹

Affiliations

PMID: 24252445
PMCID: PMC3842792
DOI: 10.1186/1745-6215-14-391

Comment

Response to: Practical methods for incorporating summary time-to-event data into meta-analysis

Yu Wang et al. Trials. 2013.

. 2013 Nov 19;14(1):391.

doi: 10.1186/1745-6215-14-391.

Authors

Yu Wang, Tingting Zeng¹

Affiliation

¹ Adverse Drug Reaction Monitoring Centre of Chengdu, 366 Jincheng Avenue, High-tech District, Chengdu, China. bettyzeng@foxmail.com.

PMID: 24252445
PMCID: PMC3842792
DOI: 10.1186/1745-6215-14-391

Abstract

A response to and comment on Practical methods for incorporating summary time-to-event data into meta-analysis, by Jayne F Tierney et al.

PubMed Disclaimer

Comment in

Response to: Practical methods for incorporating summary time-to-event data into meta. Authors' reply.
Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Tierney JF, et al. Trials. 2013;14:391. Epub 2013 Nov 19. Trials. 2013. PMID: 24511621 No abstract available.

Comment on

Practical methods for incorporating summary time-to-event data into meta-analysis.
Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Tierney JF, et al. Trials. 2007 Jun 7;8:16. doi: 10.1186/1745-6215-8-16. Trials. 2007. PMID: 17555582 Free PMC article.

Cited by

Comprehensive evaluation of microRNA-10b in digestive system cancers reveals prognostic implication and signaling pathways associated with tumor progression.
Shen Y, Dai X, Chen H, Zhai S, Peng Q, Cai S, Zhu Y, Huan J, Shen Y. Shen Y, et al. J Cancer. 2021 May 13;12(13):4011-4024. doi: 10.7150/jca.51303. eCollection 2021. J Cancer. 2021. PMID: 34093806 Free PMC article.
Comparing overall survival between first generation EGFR-TKIs and chemotherapy in lung cancer patients with Del19/L858R.
Deng W, Lei Y, Liu S, Yang J, Tu H, Yan H, Wu Y. Deng W, et al. Chin J Cancer Res. 2016 Jun;28(3):339-47. doi: 10.21147/j.issn.1000-9604.2016.03.08. Chin J Cancer Res. 2016. PMID: 27478319 Free PMC article.
Cytoplasmic SQSTM1/ P62 Accumulation Predicates a Poor Prognosis in Patients with Malignant Tumor.
Zhu L, Wang Y, He J, Tang J, Lv W, Hu J. Zhu L, et al. J Cancer. 2018 Oct 18;9(21):4072-4086. doi: 10.7150/jca.26399. eCollection 2018. J Cancer. 2018. PMID: 30410612 Free PMC article.
Role and efficacy of capecitabine in the anthracycline-free regimen in breast cancer patients: a systematic review and meta-analysis.
Wang S, Deng L, Chen J, Li Y, Zhong Y, Wang Y, Cao H. Wang S, et al. J Cancer Res Clin Oncol. 2023 Dec;149(19):17671-17682. doi: 10.1007/s00432-023-05459-7. Epub 2023 Oct 27. J Cancer Res Clin Oncol. 2023. PMID: 37891407 Free PMC article.
FZD1/KLF10-hsa-miR-4762-5p/miR-224-3p-circular RNAs axis as prognostic biomarkers and therapeutic targets for glioblastoma: a comprehensive report.
Jia F, Zhang L, Jiang Z, Tan G, Wang Z. Jia F, et al. BMC Med Genomics. 2023 Feb 8;16(1):21. doi: 10.1186/s12920-023-01450-w. BMC Med Genomics. 2023. PMID: 36755291 Free PMC article.

See all "Cited by" articles

References

1. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16. doi: 10.1186/1745-6215-8-16. - DOI - PMC - PubMed
1. Z Score to P Value Calculator[http://www.easycalculation.com/statistics/p-value-for-z-score.php]
1. Li XS. Medical Statistics(version 2) Beijing: Higher Education Press; 2008.
1. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998;17:2815–2834. doi: 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8. - DOI - PubMed
1. International Collaboration of Trialists on behalf of the Medical Research Council Advanced Bladder Cancer Working Party, EORTC Genito-urinary Group Australian Bladder Cancer Study Group, National Cancer Institute of Canada Clinical Trials Group, Finnbladder, Norwegian Bladder Cancer Study Group and Club Urológico Español de Tratamiento Oncológico (CUETO) group Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. Lancet. 1999;354:533–540. doi: 10.1016/S0140-6736(99)02292-8. - DOI - PubMed

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations

[1] Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16. doi: 10.1186/1745-6215-8-16. - DOI - PMC - PubMed

[2] Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16. doi: 10.1186/1745-6215-8-16. - DOI - PMC - PubMed

[3] Z Score to P Value Calculator[http://www.easycalculation.com/statistics/p-value-for-z-score.php]

[4] Z Score to P Value Calculator[http://www.easycalculation.com/statistics/p-value-for-z-score.php]

[5] Li XS. Medical Statistics(version 2) Beijing: Higher Education Press; 2008.

[6] Li XS. Medical Statistics(version 2) Beijing: Higher Education Press; 2008.

[7] Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998;17:2815–2834. doi: 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8. - DOI - PubMed

[8] Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998;17:2815–2834. doi: 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8. - DOI - PubMed

[9] International Collaboration of Trialists on behalf of the Medical Research Council Advanced Bladder Cancer Working Party, EORTC Genito-urinary Group Australian Bladder Cancer Study Group, National Cancer Institute of Canada Clinical Trials Group, Finnbladder, Norwegian Bladder Cancer Study Group and Club Urológico Español de Tratamiento Oncológico (CUETO) group Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. Lancet. 1999;354:533–540. doi: 10.1016/S0140-6736(99)02292-8. - DOI - PubMed

[10] International Collaboration of Trialists on behalf of the Medical Research Council Advanced Bladder Cancer Working Party, EORTC Genito-urinary Group Australian Bladder Cancer Study Group, National Cancer Institute of Canada Clinical Trials Group, Finnbladder, Norwegian Bladder Cancer Study Group and Club Urológico Español de Tratamiento Oncológico (CUETO) group Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. Lancet. 1999;354:533–540. doi: 10.1016/S0140-6736(99)02292-8. - DOI - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Response to: Practical methods for incorporating summary time-to-event data into meta-analysis

Affiliation

Response to: Practical methods for incorporating summary time-to-event data into meta-analysis

Authors

Affiliation

Abstract

Comment in

Comment on

Similar articles

Cited by

References

Publication types

LinkOut - more resources

Full Text Sources

Other Literature Sources